Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
Todd A. Smitherman(University of Mississippi), Eric Pearlman(University of California, San Francisco), Gretchen E. Tietjen(University of Vermont), Kory Schuh(Eli Lilly (United States)), Deborah N. D’Souza(Syneos Health (United States)), Vladimir Skljarevski(Eli Lilly (United States)), Sarah Lipsius(Syneos Health (United States))
Cited by 35
Related Papers
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
|Nature Communications|2016|446